http://orcid.org/0000-0003-3448-5555
Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yali Li, Jialing Xiao, Yi Sun, Hong Fang & Jianjun Qiao. (2023) Quick Treatment of Very Severe Refractory Hand and Foot Eczema with Dupilumab: A Case Report and Literature Review. Journal of Asthma and Allergy 16, pages 1-8.
Read now
Read now
Jinpeng Shan, Kamran Ali, Jiayang Da, Menghua Li, Yunmi Qiu, HaiYue Lou & Liming Wu. (2022) Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients. Clinical, Cosmetic and Investigational Dermatology 15, pages 2437-2443.
Read now
Read now
Maria Maddalena Sirufo, Alessandra Catalogna, Martina Raggiunti, Francesca De Pietro, Lia Ginaldi & Massimo De Martinis. (2022) Cholinergic Urticaria, an Effective and Safe “Off Label” Use of Dupilumab: A Case Report with Literature Review. Clinical, Cosmetic and Investigational Dermatology 15, pages 253-260.
Read now
Read now
Jiehyun Jeon, Fang Wang, Asima Badic & Brian S. Kim. (2022) Treatment of patients with chronic pruritus of unknown origin with dupilumab. Journal of Dermatological Treatment 33:3, pages 1754-1757.
Read now
Read now
Davide Chesini, MS & Marco Caminati, MD. (2022) Vitamin B12 and Atopic Dermatitis: Any Therapeutic Relevance For Oral Supplementation?. Journal of Dietary Supplements 19:2, pages 238-242.
Read now
Read now
Articles from other publishers (41)
Joana Xará, Maria Relvas, Carolina Figueiredo, Joana Calvão, Mariana Batista & Leonor Ramos. (2023) Dupilumab in the treatment of dystrophic epidermolysis bullosa: off‐label use in a pediatric patient. International Journal of Dermatology 62:12.
Crossref
Crossref
Nikolay N. Murashkin, Leonid A. Opryatin, Ekaterina S. Pavlova, Roman V. Epishev, Alexandr I. Materikin, Roman A. Ivanov, Alena A. Savelova & Maria A. Leonova. (2023) Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases. Current Pediatrics 22:5, pages 443-449.
Crossref
Crossref
Aishwarya Ashokbhai Ramani, Shiti Bose, Bhushan Madke, Arjun Rajendra Prakashey & Samyak Ganjre. (2023) A review of biological agents and small molecules in the management of atopic dermatitis. Indian Journal of Skin Allergy 2, pages 51-59.
Crossref
Crossref
Nicolas Andre & Amir Horev. (2023) The top 100 most cited contributions on prurigo nodularis: A bibliometric analysis. Clinics in Dermatology 41:5, pages 650-654.
Crossref
Crossref
Nicolas Andre & Amir Horev. (2023) The top 100 most cited contributions on prurigo nodularis: A bibliometric analysis. Clinics in Dermatology 41:4, pages 540-544.
Crossref
Crossref
Shou-En WuYi-Hsien ChenChi-Hsiang ChungGwo-Jang WuChang-Huei TsaoChien-An SunWu-Chien ChienChih-Tsung Hung. (2023) Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study. Dermatitis® 34:3, pages 241-249.
Crossref
Crossref
Juexin Chen, Hui Huang, Liehua Deng & Shi Wu. (2023) Dupilumab as monotherapy for bullous pemphigoid with multiple underlying diseases: A report of two cases. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-3.
Crossref
Crossref
Heinrich Dickel. (2023) Management von Kontaktekzemen. Allergo Journal 32:3, pages 16-38.
Crossref
Crossref
Gaetano Licata, Vittorio Tancredi, Giulia Calabrese, Dario Buononato, Alina De Rosa, Giuseppe Argenziano & Alessio Gambardella. (2022)
Management of alopecia areata in
JAK
‐inhibitors era: are systemic and topical corticosteroids still useful?
. International Journal of Dermatology 62:4.
Crossref
Crossref
Henning Olbrich, Christian D. Sadik, Ralf J. Ludwig, Diamant Thaçi & Katharina Boch. (2023) Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules 13:4, pages 634.
Crossref
Crossref
Heinrich Dickel. (2023) Management of contact dermatitis. Allergo Journal International 32:3, pages 57-76.
Crossref
Crossref
Allen Kaplan, Mark Lebwohl, Ana M. Giménez‐Arnau, Michihiro Hide, April W. Armstrong & Marcus Maurer. (2022) Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. Allergy 78:2, pages 389-401.
Crossref
Crossref
Ji-Hyun Lee, Ji-Ye Lim, Yong-Deok Jeon, Dae-Ho Yun, Young-Mi Lee & Dae-Ki Kim. (2022) Extract of Wheatgrass and Aronia Mixture Ameliorates Atopic Dermatitis-Related Symptoms by Suppressing Inflammatory Response and Oxidative Stress In Vitro and In Vivo. Antioxidants 12:1, pages 27.
Crossref
Crossref
Lan Guo, Yue‐Ping Zeng & Hong‐Zhong Jin. (2022) Reactive perforating collagenosis treated with dupilumab: A case report and literature review. Dermatologic Therapy 35:12.
Crossref
Crossref
Jacob T. Kingsley, Erica B. Lee & Jennifer L. Adams. (2022) A case of annular erythema of infancy accompanied by elevated tryptase. Pediatric Dermatology 39:5, pages 748-751.
Crossref
Crossref
Y.G. Koh, J.W. Park, S.H. Shin, B.J. Kim & K.H. Yoo. (2022) Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 36:8.
Crossref
Crossref
Mengxin Wang, Juan Wang & Bingjun Shi. (2022) Case report: Dupilumab for the treatment of bullous pemphigoid. Dermatologic Therapy 35:7.
Crossref
Crossref
Danitza Lukac, Kyla Pagani & Jean S. McGee. (2022) Overview of use, efficacy, and safety of dupilumab in complex patients: a retrospective, case-series study from a large, urban academic center. Archives of Dermatological Research 315:6, pages 1777-1781.
Crossref
Crossref
Ilaria Sammarra, Luigi Bennardo, Eugenio Provenzano, Cataldo Patruno & Steven Paul Nisticò. (2022) Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report. Brain Sciences 12:5, pages 605.
Crossref
Crossref
Heinrich Dickel, Andrea Bauer, Randolf Brehler, Vera Mahler, Hans F. Merk, Irena Neustädter, Klaus Strömer, Thomas Werfel, Margitta Worm & Johannes Geier. (2022) S1‐Leitlinie Kontaktekzem. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 711-734.
Crossref
Crossref
Heinrich Dickel, Andrea Bauer, Randolf Brehler, Vera Mahler, Hans F. Merk, Irena Neustädter, Klaus Strömer, Thomas Werfel, Margitta Worm & Johannes Geier. (2022) German S1 guideline: Contact dermatitis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 712-734.
Crossref
Crossref
Sukhbir Singh, Tapan Behl, Neelam Sharma, Ishrat Zahoor, Sridevi Chigurupati, Shivam Yadav, Mahesh Rachamalla, Aayush Sehgal, Tanveer Naved, Pritima, Sandeep Arora, Saurabh Bhatia, Ahmed Al-Harrasi, Syam Mohan, Lotfi Aleya & Simona Bungau. (2022) Targeting therapeutic approaches and highlighting the potential role of nanotechnology in atopic dermatitis. Environmental Science and Pollution Research 29:22, pages 32605-32630.
Crossref
Crossref
Bocui Song, Xue Shen, Shuang Zhang, Rui Zhao, Yanhong Wang, Mengmeng Jiang, Min Liu, Qian Chen, Yuqi Li, Baolei Huang, Chenghao Jin & Chunyu Tong. (2022) Effects of Fisetin on Allergic Contact Dermatitis via Regulating the Balance of Th17/Treg in Mice. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Crossref
Maya Firsowicz, TylerJ Willenbrink, Nova Shu & JasonS Reichenberg. (2022) Successful use of dupilumab for treatment-resistant pityriasis amiantacea. Journal of Dermatology and Dermatologic Surgery 26:3, pages 3.
Crossref
Crossref
Lina Belmesk, Anastasiya Muntyanu, Emmanuelle Cantin, Zeinah AlHalees, Carolyn S. Jack, Michelle Le, Denis Sasseville, Lisa Iannattone, Moshe Ben-Shoshan, Ivan V. Litvinov & Elena Netchiporouk. (2021) Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 26:1, pages 33-49.
Crossref
Crossref
Dan Slodownik, Assi Levi, Moshe Lapidoth & Shlomo Moshe. (2022) Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series. Dermatology 238:6, pages 1073-1075.
Crossref
Crossref
Zahava Vadasz & Elias Toubi. 2021. Urticaria - Diagnosis and Management. Urticaria - Diagnosis and Management.
Olayemi Sokumbi, Huma Shamim, Mark Dennis P. Davis, David A. Wetter, Catherine C. Newman & Nneka Comfere. (2021) Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates. The American Journal of Dermatopathology 43:10, pages 714-720.
Crossref
Crossref
Subaina Naeem Khalid, Zeest Ali Khan, Muhammad Hamza Ali, Talal Almas, Tarek Khedro & Vikneswaran Raj Nagarajan. (2021) A blistering new era for bullous pemphigoid: A scoping review of current therapies, ongoing clinical trials, and future directions. Annals of Medicine and Surgery 70, pages 102799.
Crossref
Crossref
Giuseppe Ingrasci, Zoe M. Lipman, Ahmed A. Hawash, Giampiero Girolomoni & Gil Yosipovitch. (2021) The pruritogenic role of the type 2 immune response in diseases associated with chronic itch. Experimental Dermatology 30:9, pages 1208-1217.
Crossref
Crossref
Ayelet Ollech, Jacob Mashiah, Atar Lev, Amos J. Simon, Raz Somech, Etai Adam, Aviv Barzilai, David Hagin & Shoshana Greenberger. (2021) Treatment options for DOCK8 deficiency‐related severe dermatitis. The Journal of Dermatology 48:9, pages 1386-1393.
Crossref
Crossref
Damien Abreu & Brian S. Kim. (2021) Innate Immune Regulation of Dermatitis. Immunology and Allergy Clinics of North America 41:3, pages 347-359.
Crossref
Crossref
Chung-Chi Yang, Yen-Ling Hung, Wen-Chin Ko, Yi-Ju Tsai, Jia-Feng Chang, Cher-Wei Liang, Der-Chen Chang & Chi-Feng Hung. (2021) Effect of Neferine on DNCB-Induced Atopic Dermatitis in HaCaT Cells and BALB/c Mice. International Journal of Molecular Sciences 22:15, pages 8237.
Crossref
Crossref
Franz J. Legat. (2021) Itch in Atopic Dermatitis – What Is New?. Frontiers in Medicine 8.
Crossref
Crossref
Mary Kathryn Abel, Alyssa G. Ashbaugh, Honor Fullerton Stone & Jenny E. Murase. (2021) The use of dupilumab for the treatment of recalcitrant brachioradial pruritus. JAAD Case Reports 10, pages 69-71.
Crossref
Crossref
Simone Garcovich, Martina Maurelli, Paolo Gisondi, Ketty Peris, Gil Yosipovitch & Giampiero Girolomoni. (2021) Pruritus as a Distinctive Feature of Type 2 Inflammation. Vaccines 9:3, pages 303.
Crossref
Crossref
Reiko Kageyama, Taisuke Ito, Shiho Hanai, Naomi Morishita, Shinsuke Nakazawa, Toshiharu Fujiyama, Tetsuya Honda & Yoshiki Tokura. (2021) Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata. International Journal of Molecular Sciences 22:5, pages 2618.
Crossref
Crossref
Amanda G. Zhou, Alicia J. Little & Richard J. Antaya. (2020) Epidermolysis bullosa pruriginosa treated with dupilumab. Pediatric Dermatology 38:2, pages 526-527.
Crossref
Crossref
Enzo Errichetti & Giuseppe Stinco. (2021) Recalcitrant chronic urticaria treated with dupilumab: Report of two instances refractory to H1‐antihistamines, omalizumab and cyclosporine and brief literature review. Dermatologic Therapy 34:2.
Crossref
Crossref
Simran Chadha, Andrew J. Para & Jennifer Choi. (2020) Management of Immune-Related Cutaneous Adverse Reactions to PD-1 and PD-L1 Inhibitors for the Inpatient Dermatologist. Current Dermatology Reports 9:4, pages 231-243.
Crossref
Crossref
Ana M. Giménez-Arnau & Andaç Salman. (2020) Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress. Drugs 80:16, pages 1617-1634.
Crossref
Crossref